Siemens Healthineers joins collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease ...
The ID.4 was well-received when it debuted in 2021, and the model had a mostly strong 2025, selling 31 percent more than the ...
Stable patients who stop taking beta-blockers a year or more after a heart attack fare no worse than those who keep taking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results